Cichoric acid plays an important role in reducing hepatic steatosis, as it reduces the expression of lipogenic actors, such as SREBP-1c, DGAT1, FAS, and SCD-1, and also of inflammatory factors such as IL-6, IL-1b, NF-κB, and TNF-α. Here, SREBF1 is linked to fatty liver disease.